Cargando…
Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer
17β-Estradiol (E2) controls diverse physiological processes, including cell proliferation, through its binding to estrogen receptor α (ERα). E2:ERα signaling depends on both the receptor subcellular localization (e.g., nucleus, plasma membrane) and intracellular ERα abundance. Indeed, the control of...
Autores principales: | Bartoloni, Stefania, Leone, Stefano, Acconcia, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279444/ https://www.ncbi.nlm.nih.gov/pubmed/32408555 http://dx.doi.org/10.3390/ijms21103418 |
Ejemplares similares
-
Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation
por: Totta, Pierangela, et al.
Publicado: (2016) -
The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane
por: Acconcia, Filippo, et al.
Publicado: (2011) -
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells
por: Pescatori, Sara, et al.
Publicado: (2022) -
The antiviral drug telaprevir induces cell death by reducing
FOXA1
expression in estrogen receptor α (ERα)‐positive breast cancer cells
por: Bartoloni, Stefania, et al.
Publicado: (2022) -
Lysosomal Function Is Involved in 17β-Estradiol-Induced Estrogen Receptor α Degradation and Cell Proliferation
por: Totta, Pierangela, et al.
Publicado: (2014)